A
Price
$134.59
Change
-$2.12 (-1.55%)
Updated
Apr 17, 6:59 PM EST
33 days until earnings call
ILMN
Price
$118.29
Change
+$0.60 (+0.51%)
Updated
Apr 17, 6:59 PM EST
14 days until earnings call
Ad is loading...

A vs ILMN ᐉ Comparison: Which is Better to Invest?

Header iconA vs ILMN Comparison
Open Charts A vs ILMNBanner chart's image
Agilent Technologies
Price$134.59
Change-$2.12 (-1.55%)
Volume$743.08K
CapitalizationN/A
Illumina
Price$118.29
Change+$0.60 (+0.51%)
Volume$779.14K
CapitalizationN/A
View a ticker or compare two or three
A vs ILMN Comparison Chart

Loading...

ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
ILMNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
A vs. ILMN commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and ILMN is a Hold.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (A: $134.55 vs. ILMN: $118.29)
Brand notoriety: A: Not notable vs. ILMN: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 125% vs. ILMN: 114%
Market capitalization -- A: $42.66B vs. ILMN: $21.09B
A [@Medical Specialties] is valued at $42.66B. ILMN’s [@Medical Specialties] market capitalization is $21.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • ILMN’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than ILMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 3 TA indicator(s) are bullish while ILMN’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 3 bullish, 5 bearish.
  • ILMN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ILMN is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -6.67% price change this week, while ILMN (@Medical Specialties) price change was -9.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.50%. For the same industry, the average monthly price growth was -3.69%, and the average quarterly price growth was +10.07%.

Reported Earning Dates

A is expected to report earnings on May 21, 2024.

ILMN is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Medical Specialties (-3.50% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for A with price predictions.
OPEN
A.I.dvisor published
a Summary for ILMN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than ILMN($21.1B). ILMN has higher P/E ratio than A: ILMN (49.50) vs A (34.82). A YTD gains are higher at: -3.065 vs. ILMN (-15.477). A has higher annual earnings (EBITDA): 1.69B vs. ILMN (-608M). ILMN has less debt than A: ILMN (2.26B) vs A (2.56B). A has higher revenues than ILMN: A (6.74B) vs ILMN (4.5B).
AILMNA / ILMN
Capitalization42.7B21.1B202%
EBITDA1.69B-608M-278%
Gain YTD-3.065-15.47720%
P/E Ratio34.8249.5070%
Revenue6.74B4.5B150%
Total CashN/A1.05B-
Total Debt2.56B2.26B113%
FUNDAMENTALS RATINGS
A vs ILMN: Fundamental Ratings
A
ILMN
OUTLOOK RATING
1..100
5658
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
4695
PRICE GROWTH RATING
1..100
5158
P/E GROWTH RATING
1..100
5190
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (18) in the Biotechnology industry is somewhat better than the same rating for ILMN (83). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for ILMN (100). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for ILMN (95). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's Price Growth Rating (51) in the Biotechnology industry is in the same range as ILMN (58). This means that A’s stock grew similarly to ILMN’s over the last 12 months.

A's P/E Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for ILMN (90). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AILMN
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 3 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 29 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 3 days ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 3 days ago
72%
View a ticker or compare two or three
Ad is loading...
ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
ILMNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOGZ7.680.96
+14.29%
Dogness (International) Corp
TNGX7.460.11
+1.50%
Tango Therapeutics
FFNW20.37-0.03
-0.15%
First Financial Northwest
SITC13.44-0.06
-0.44%
SITE Centers Corp
TXT92.21-1.03
-1.10%
Textron

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
-2.86%
RVTY - ILMN
59%
Loosely correlated
-1.99%
BRKR - ILMN
56%
Loosely correlated
-2.17%
IQV - ILMN
50%
Loosely correlated
-0.87%
CRL - ILMN
49%
Loosely correlated
-1.52%
TMCI - ILMN
48%
Loosely correlated
-2.95%
More